Intermodal market trends signal a return to stability, but warning signs lie ahead
International container imports are surging as businesses pull forward inventory, but a decline in manufacturing, geopolitical conflict, and election worries cloud the future.
Gary Frantz is a contributing editor for DC Velocity and its sister publication CSCMP's Supply Chain Quarterly, and a veteran communications executive with more than 30 years of experience in the transportation and logistics industries. He's served as communications director and strategic media relations counselor for companies including XPO Logistics, Con-way, Menlo Logistics, GT Nexus, Circle International Group, and Consolidated Freightways. Gary is currently principal of GNF Communications LLC, a consultancy providing freelance writing, editorial and media strategy services. He's a proud graduate of the Journalism program at California State University–Chico.
It’s been an up and down year for the intermodal rail industry. Severe weather impacted operations early in the year. Yet the market absorbed those challenges and staged a modest recovery. By the end of the second quarter, total intermodal volumes had risen 7.9% year over year, according to the Intermodal Association of North America’s 2024 second-quarter report, released July 29. International containers, those 20- and 40-foot TEUs (20-foot equivalent units) coming into the nation’s ports, rose 13.3%. Domestic intermodal traffic, typically 53-foot containers, improved 5.0%, while trailers fell 20.6%.
“International volume provided the biggest lift,” noted Joni Casey, IANA’s president and CEO, who is retiring at the end of the year, in a news release announcing the report. “Domestic containers played a supporting role, especially important as the decline in TOFC [trailer on flatcar] moves continued.” Total IMC (intermodal marketing company) volumes increased 5.5% year over year in Q2, she added.
Nevertheless, troubling signs are on the horizon that could derail the market’s newfound stability. According to the Institute for Supply Management’s “Manufacturing ISM Report on Business” for August, economic activity in the manufacturing sector contracted in August for the fifth consecutive month (as measured on a year-over-year basis). But compared to July, the August index was up slightly to 47.2, or 0.4 percentage points.
And while the overall economy continued its expansion for the 52nd consecutive month (after one month of contraction in April 2020), U.S. manufacturing activity remained in contraction territory, the report’s author, Timothy R. Fiore, chair of the ISM’s Manufacturing Business Survey Committee, said.
“U.S. manufacturing activity contracted slower compared to last month. Demand continues to be weak, output declined, and inputs stayed accommodative,” he said in a statement, adding that three key related indexes—New Orders, New Export Orders, and Backlog of Orders—“remained in strong contraction territory.”
One silver lining has been the U.S. consumer, who has kept spending at a positive yet measured pace, providing an underpinning for the overall economy. That’s been good news for intermodal service providers looking for a more sustained recovery.
WHAT’S AN OPERATOR TO DO?
Larry Gross, founder and president of Gross Transportation Consulting,has seen any number of market cycles over his decades of work in the intermodal industry. “There is a lot of churn, a lot of uncertainty in the markets right now,” he’s observed. A lot of freight moved earlier in the year as shippers took steps to pull forward inventory in an attempt to avoid potential disruptions from various issues.
Those issues include a potential East and Gulf Coast port strike, labor unrest with Canada’s railroads (workers are now back on the job while their contract is in arbitration), continued geopolitical hostilities, concerns over the upcoming election, and the prospect of future new tariffs on a variety of imports next year.
Worries over a disruption at East Coast ports in particular “have caused a swing to the West Coast in terms of TEUs coming into North America,” says Gross. “There has definitely been a diversion,” he adds, citing container volumes out of the Pacific Northwest that were up 83% in July over last year. “The PNW is getting really congested,” and that, Gross says, is part of the reason why the Los Angeles and Long Beach ports are seeing container volumes surge as well. “It’s a reversal of a long-term trend, which was west-to-east migration.”
Those trends also reflect routing decisions made months ago by shippers to avoid potential port strike disruptions, and which will take months to unwind, Gross points out. “Containers on the water today, headed to West Coast ports and eventually destined for transfer to intermodal trains, are based on decisions shippers made in the spring or before. They’re set in stone,” he says. So as intermodal operators look at that incoming traffic, they have to plan for and start repositioning assets to handle those volumes at those ports. And that takes time.
“August and September are typically the biggest months for international,” Gross adds. “October is the biggest month for domestic. The rail network, from all indications, is running smoothly. Trains generally have recovered [from earlier operating hiccups] and are running consistently, but it takes time for the system to fully reset,” he says, and it could take months for the system to balance out.
PLENTY OF CAPACITY
Intermodal rail capacity is not an issue, according to several reports. Whereas ample capacity and rate competition through most of 2024 caused shippers to move some freight from rail to road, “the bleeding has stopped,” says Gross. “The erosion of share from intermodal to truck” has subsided, and rail intermodal operators are working hard to “claw that traffic back,” he adds.
Of the overall volume of truckload freight moving 500 miles or more, excluding ISO container moves (moves of international intermodal containers coming off ships), domestic intermodal accounts for about 6% of the market, with truck accounting for 94%. During the pandemic, intermodal’s share hit nearly 7%. For the past six quarters, that share has returned to the more typical 6%.
“I am of the opinion that the market we are in right now with regard to freight is not that unusual,” says Gross. “We are not that far off” [from a more balanced market],” he adds. “[The railroads] have removed poor service as a reason for shippers to abandon intermodal. Now the door is open, and they have to close the sale.” For a shipper who is close to an origin and destination intermodal terminal, “it is almost unbeatable.”
Indeed, Class 1 railroads are making operational improvements, investing in capacity and infrastructure, and gearing up to aggressively go after more intermodal business as the year proceeds, buoyed by surging international import volumes, according to several industry sources.
At Union Pacific, which generated $5.6 billion in second-quarter revenue, “service levels and network performance for the second quarter remained strong, demonstrating our recoverability in the wake of major weather disruptions,” said Eric Gehringer, UP’s executive vice president of operations, in the company’s recent second-quarter earnings call. Freight car velocity was flat, as improvements in terminal dwell were offset by weather-related drops in train speeds.
He sees opportunity to drive stronger terminal dwell performance “by removing unnecessary car touches across the network.” Results also benefited from a 6% improvement in locomotive productivity driven by better network fluidity and improved asset utilization. Train length improved 2%, with June marking the first month ever with a UP train length over 9,600 feet. “That’s a remarkable achievement by the team as they continue to generate mainline capacity for future growth,” Gehringer said.
Looking ahead, Jennifer Hamann, UP’s executive vice president and CFO, noted “a lot of the drivers that were present in the second quarter are going to be present at least into the third quarter. International intermodal is staying strong, [and] coal is weaker.” On the industrial side of the business, Hamann said, “while we have great business development opportunities, there’s a little softness there.”
Added Jim Vena, UP’s CEO: “We’ve got a great team. They know what the end goal is. So I see us optimizing the railroad and getting better at how we operate.” Yet what really will help improve UP’s operating margin, Vena believes, “is revenue growth. We are pushing hard on that piece by both bringing in volume at the right price” and managing pricing effectively to account for inflation and other cost challenges the railroad has endured.
A FOCUS ON SERVICE
At BNSF, the railroad is leveraging a $3.92 billion capital plan this year to, among other things, add main track miles, expand intermodal parking, add rolling stock, increase production capacity at intermodal yards, improve technology, and make “resiliency investments” to harden its network against extreme weather conditions, according to Kendall Sloan, BNSF’s director of external communications.
“BNSF’s reach is broader than any other Class 1 railroad,” she notes. The railroad operates 32,500 miles of track, providing “direct access to the country’s biggest … inland markets and multiple service options,” with particular attention to customer service.
One example she cites is the BNSF’s partnership with intermodal operator J.B. Hunt. Last fall, the two companies jointly launched Quantum, a new intermodal service “to accommodate the service-sensitive highway freight needs of customer supply chains,” she says. Citing as its hallmarks consistency, agility, and speed, Sloan says Quantum is averaging “up to 98% on-time delivery,” generally providing a service that is a day faster than traditional intermodal.
On the technology side, BNSF has been investing in and deploying new technologies to better leverage data to provide improved analytics and support safety improvements. Among those have been “brake health effectiveness detectors, drones,” and other advanced equipment, software tools, and systems, all designed to provide more timely and accurate data. On the labor front, BNSF as of Sept. 4 had reached tentative collective bargaining agreements with six of its labor unions, months ahead of schedule. The agreements will now need to be ratified by covered employees.
In preparation for the upswing in demand expected from this year’s domestic intermodal peak season, BNSF since early July has deployed additional train crews, locomotives, and railcars across the Pacific Northwest, California, and Texas. The railroad so far has seen a 40% increase in Inland Point Intermodal (IPI) volumes (IPI moves are cargoes going from a port to a shipper’s door in the interior of the country via a domestic or international intermodal container), handling a record number of on-dock railcar loadings from Southern California’s ports of Los Angeles and Long Beach in the first half of this year.
What are intermodal customers asking for? Reliable capacity; safe, efficient operations; and consistent, reliable performance that meets expected delivery times at a reasonable cost. For Class 1 railroads, that means continued investments across the board. Among BNSF’s initiatives in this regard are a planned multibillion-dollar investment in its Barstow (California) International Gateway and a master-planned logistics hub in Arizona’s Maricopa County.
“We know that our customers always are looking for new ways to move their shipments as safely and quickly as possible,” notes Sloan. That’s the underlying incentive for both the rail’s billion-dollar investments in the network and its focus on safety, exemplified by the railroad’s finishing last year with “the fewest injuries in BNSF’s history,” Sloan says. “We continue to lead the industry in safety and are committed to continuous improvement.”
OPPORTUNITIES AHEAD
As the intermodal rail market settles back to prepandemic levels, there remain opportunities, yet the constant competitive tug of war between over-the-road trucking and intermodal shows no signs of abating. IANA’s Casey expects the industry to continue to deliver modest growth—a prediction that was borne out in July’s and August’s upbeat volume numbers—fueled by containerized import traffic returning to the West Coast, which has seen double-digit gains for most of the year.
Domestic container growth, however, has not been as strong “due to tougher year-over-year comparisons and competition with over-the-road trucking,” she notes. “Still, modest growth of industrial activity and transloads from West Coast imports have provided a tailwind.”
With peak season in full swing, she believes the industry can avoid the congestion issues experienced during the pandemic. “Fleet owners have signaled that container velocity continues to trend to prepandemic levels. The intermodal network appears to have [sufficient] assets in place. And there has been no mention of any chassis supply constraints,” she says.
Yet challenges are looming. Among the most worrying to shippers is the prospect of a strike at East and Gulf Coast ports. “This would be disruptive not only for those locations, but also for a good portion of the intermodal supply chain,” she believes. “That would force shippers to execute contingency plans.” Other concerns center on the upcoming election, the prospect of higher tariffs under a new administration, and other disruptive “black swan” events.
On the opportunity side of the ledger, Casey cites the growth of nearshoring and reshoring as companies move operations from Asia to Mexico, increasing opportunity for cross-border U.S.-Mexico moves. She also cites transloading and the potential for domestic intermodal growth as well as the accelerating demand for “sustainable” transportation driven by clean air initiatives.
At its core, in her view, the intermodal rail industry still has three primary advantages over highway truckload service: “environmental stewardship, service consistency, and cost savings.” And those are advantages that will continue to endure and deliver sustainable value in any market cycle.
Its latest expansion adds both specialized U.S./Mexico cross-border and international trade compliance services. "JAMCO's capabilities align perfectly with our growth strategy and commitment to providing comprehensive, highly specialized premium logistics solutions,” Imperative CEO Dante Fornari said in a release. “JAMCO will significantly enhance our service offering by adding highly differentiated and integrated cross-border trade and logistics services. We'll be better positioned to support existing customers who manufacture in Mexico while providing JAMCO clients with our expedited mission-critical shipping and global forwarding capabilities."
According to Imperative, that move is significant because Laredo, Texas-based JAMCO is well located to serve the growing nearshoring trend that saw Mexico become the largest trading partner of the United States in 2023, surpassing China with over $800 billion in trade value. Amid that growth, Laredo, Texas, has also solidified its role as the top U.S. port, measured by trade value, representing approximately 40% of all U.S.-Mexico trade flows.
Seagull Software, which makes “BarTender” label management software, today said it has combined with Mojix, a provider of item-level inventory management and traceability.
As a single company, the combined firms will offer new capabilities in end-to-end supply chain management, leveraging BarTender’s global customer base and value-added channel partner network with more than 250,000 customers across 175 countries.
“We believe that labeling is the key to addressing the traceability challenge,” Dan Doles, now acting CEO and Director of Seagull, said in a release. “BarTender’s labeling software is ubiquitous at the front end of the supply chain, enabling the printing of more than 100 billion labels each year. By combining with Mojix, we will capture and track that data through the supply chain, providing unparalleled item-level traceability and visibility.”
That approach will allow the partners to provide their customers with value-added solutions for compliance, sustainability, serialization, and inventory and asset management requirements across the supply chain ecosystem, according to Chris Cassidy, the newly appointed Chief Revenue Officer of Seagull.
The features are based on SAP’s “generative AI copilot” platform called Joule, launched about a year ago. The latest upgrades to that product add collaborative AI agents that truly speak the language of business, expand Joule’s capabilities to support 80% of SAP’s most-used business tasks, and embed Joule more deeply within the company’s portfolio.
Specifically, collaborative multi-agent systems can now deploy specialized AI agents to tackle specific tasks and enable them to collaborate on intricate business workflows, adapting their strategies to meet shared objectives. SAP is infusing Joule with multiple collaborative AI agents that will combine their unique expertise across business functions to collaboratively accomplish complex workflows. These AI agents enhance productivity by breaking down silos and freeing workers to concentrate on areas where human ingenuity thrives.
And Walldorf, Germany-based SAP also said it had met its goal to train workers how to use those powerful new AI tools by upskilling 2 million people worldwide by 2025. That approach has lowered the world’s digital skills gap through role-based certifications, free training materials, and hands-on opportunities for developers. To continue that program, SAP says it will continue to expand its portfolio of AI-related learning opportunities, including courses on generative AI, AI ethics, and the company’s advanced AI tools and platforms.
For players in the drug distribution business, the countdown is on. In less than two months, every business involved in the pharmaceutical supply chain must be fully compliant with the Drug Supply Chain Security Act (DSCSA)—a 2013 law containing strict traceability requirements for the distribution of certain prescription drugs. Over the past decade, the DSCSA has been implemented in phases, but now the clock is running out. The law takes full effect on Nov. 27, barring any further adjustments or delays.
Among other measures, the DSCSA requires drug manufacturers to affix a unique product identifier, essentially a barcode, to every package so it can be tracked and traced during its journey through the supply chain. To thwart drug counterfeiters, the new law further requires wholesalers and drug dispensers to verify the validity of products they handle to assure they are genuine.
Is the pharmaceutical industry ready for all this? To find out, we spoke with Elizabeth Gallenagh, general counsel and senior vice president, supply chain integrity at the Healthcare Distribution Alliance(HDA), a national organization that represents U.S. health-care distributors. In addition to serving as HDA’s chief legal officer, Gallenagh is also the group’s primary expert on prescription drug traceability, supply chain safety and integrity, distributor licensure, and tax issues. She is a graduate of the George Mason University School of Law and George Washington University.
Gallenagh recently spoke with David Maloney, **{DC Velocity’}s group editorial director, about the enactment of DSCSA for an episode of the “Logistics Matters” podcast.
Q: First of all, can you tell us a little bit about the Healthcare Distribution Alliance?
A: Yes, the Healthcare Distribution Alliance, or HDA, is a national trade organization representing pharmaceutical distributors, also known as wholesalers. We have about 40 members that purchase drugs from manufacturers. They store the products in their warehouses and then fill orders for pharmacy customers throughout the country.
Q: The Drug Supply Chain Security Act will go into final effect in November. What’s the intent of the legislation?
A: The Drug Supply Chain Security Act—or as we call it, the DSCSA—is a law that was enacted in 2013. Its intent was to put together a national framework for drug supply chain security, essentially to enable a tighter, safer, more secure supply chain for the domestic U.S. market.
It involves all trading partners and ultimately will create an interoperable system that enables investigations by tracing a product with every transaction or sale of that product throughout the supply chain, down to the provider level.
Q: What are the law’s major requirements?
A: The law was actually phased in over a period of about 10 years. Many of the major requirements went into effect throughout that initial 10-year period—things like requirements mandating that manufacturers serialize their products and stipulating that trading partners only do business with other authorized trading partners. Authorized trading partners are defined as those that are duly licensed or registered with the Food and Drug Administration (FDA) or licensed by the states.
It also requires tracking of product with every transaction. A transaction is defined as a sale of the product, essentially from one authorized trading partner to another. And as we progress into the final phase, the law will also require serialized data, basically transaction information at the serial-number level that moves with the product through every transaction throughout the supply chain.
Q: You’ve said that the industry has had years to ramp up to comply with the law. Are our pharmaceutical supply chains ready for the final phase?
A: I think that’s still the $64,000 question. I can speak for our members, who have been doing everything in their power to get their own systems and processes ready to receive the serialized products and data, and then to transmit that serialized data with the product to their pharmacy customers.
That said, there are still some gaps in the system. We have been in a “stabilization” period that expires on Nov. 27. During this period, everybody has been testing and bringing product and data transactions live into production. I will tell you that many are ready, but there are still bugs that are being worked out as we race toward November.
I should also note that on Aug. 19, the HDA sent a letter to the FDA stating that “despite a concerted effort, some in the supply chain appear to remain short of reaching our joint goal of complete implementation.” In its letter, the group urged the FDA to “take immediate action to forestall potential disruptions to the drug supply chain and patient care that could stem from incomplete implementation of the enhanced drug distribution security (EDDS) requirements” and asked the agency to adopt “a phased, stepwise approach” to implementing the requirements in order to avoid disruptions to the movement of drugs through the supply chain.
Q: Will penalties be imposed on companies that fail to meet the deadline?
A: There will be penalties. But it’s important to note that the DSCSA is really about setting up the framework for tracking and tracing products—so that a manufacturer will only be permitted to sell its product downstream if it is a serialized product and the manufacturer can transmit the corresponding serialized data with the product. And then a distributor can only receive that product and purchase it if it has the corresponding data.
Q: Of course, this is only possible if you have the right technology in place to monitor and track drugs as they move through the supply chain. What kind of technologies are being deployed to make this possible?
A: The key to all of this is the barcode, which is mandated under the law in terms of the way that product is serialized. Everybody in the supply chain has to have the capability to utilize the barcode. If you’re a manufacturer, you have to incorporate that 2-D barcode with the serialized data into that product’s label. And that should already be in place under the first phases of the law.
Downstream partners will have to be able to read that barcode and import that data into their systems. This also enables verification of the product at the unit level.
In addition, we’re also deploying what we call EPCIS [a global data-sharing standard developed by the global standards organization GS1 that allows businesses to capture and share information about the movement and status of goods]. That is the backbone for getting all of this serialized data flowing to all of the requisite trading partners throughout the supply chain.
Q: As we learned during the push to distribute Covid-19 vaccines, a good number of pharmaceutical products must be temperature- or humidity-controlled. Will these new regulations help ensure that they’re properly handled as they move through the supply chain?
A: The DSCSA doesn’t speak specifically to temperature controls. However, there are other parts of the law [the overall Drug Quality and Security Act, which includes the DSCSA as well as the Compounding Quality Act] that do require those controls to be in place. That said, the DSCSA does require affected parties to do business with authorized trading partners. And in order to be an authorized trading partner, you have to adhere to temperature controls and safety rules for products, product handling, etc.
Q: Many of our pharmaceuticals are manufactured overseas, in China and India, for example. Do foreign manufacturers have to comply with DSCSA requirements?
A: If a foreign entity is producing product for use in the U.S. domestic market, the product has to be approved by the FDA. And it also has to meet DSCSA requirements.
Q: We hear a lot about counterfeit products infiltrating the drug supply chain. Will these new regulations reduce the number of counterfeits in the market?
A: We certainly hope so. All of this really started [as an effort to combat the rise in] counterfeit products and transactions back in the early 2000s. Obviously, the idea is to deter counterfeiters from infiltrating the U.S. drug supply chain. But really, what the law does is provide tools for the FDA and regulatory agencies to investigate suspect and illegitimate product, as well as tools that will enable the trading partners that are involved in the transactions to identify suspect product, flag it, quarantine it, investigate it, and deem it OK or deem it illegitimate based on their investigations.
So it really gives some investigatory and prosecutorial tools to the agencies. And it puts a process in place with the technology and serialization to pinpoint whether something is good product through verification with the manufacturer or through tracing of the product data that has accompanied the product throughout its journey through the supply chain.
Q: Drug prices in the U.S. are notoriously high compared with prices in many other countries. Will these new requirements add to the overall cost of supplying medication?
A: I haven’t seen any data that alludes to DSCSA compliance adding to drug costs. It’s an industry that’s built around efficiency, and so my sense is that [pharma industry players] probably have also built in plans over the last decade to absorb some of those costs. That said, the law also established a national tracking and tracing framework, where before we had a 50-state patchwork of regulations. So there would likely be some efficiencies gained from following a single, nationwide protocol, even though it’s a huge undertaking, versus doing it 50 different ways across the country.
Q: Now that DSCSA is nearing full implementation, how are your members feeling about the process?
A: Our members have been committed to this from the very beginning. We were very involved in negotiating on the legislation and pushing these concepts. We really have been working toward implementation from the get-go and throughout this entire 11-year period; we very much want to get to full implementation. But in the beginning, there may be some hiccups. We may hit a few bumps along the way.
A colleague of mine used to say, “We don’t know what we don’t know.” And I think that at each phase as we deploy new technologies and new processes, we will learn new ways to do things more efficiently. So we’re pushing hard toward November, and we are very hopeful.
Autonomous inventory management system provider Corvus Robotics is delivering drone technology for lights-out warehouse environments with the newest version of its Corvus One drone system, announced today.
The update is supported by an $18 million funding round led by S2G Ventures and Spero Adventures.
“Corvus Robotics fits our mission to invest in companies that truly transform the way business is conducted,” Marc Tarpenning, co-founder of Tesla and partner at Spero Ventures, said in a press release Tuesday. “Other than a landing pad, its drone-powered system requires no infrastructure, is quick and easy to deploy, and cost-effective to manage. It literally merges with the existing warehouse environment.”
Corvus Robotics’ drone-based inventory management system uses computer vision and generative AI to understand its environment, flying autonomously in both very narrow aisles—a minimum width of 50 inches—and in very wide aisles. It uses obstacle detection to operate safely in warehouses and features an advanced barcode scanning system that can read any barcode symbology in any orientation placed anywhere on the front of cartons or pallets, according to the company.
The lights-out feature is already in use at customer locations.
“Being able to run inventory checks 24/7 without operator assistance has been a game changer,” Austin Feagins, senior director of solutions at third-party logistics services (3PL) provider Staci Americas, said in the release. “The lights-out capability in the Corvus One system allows our inventory teams to correct discrepancies off-shift and pre-shift before production starts each day, limiting fulfillment delays and production impacts.”